Free Trial
NASDAQ:CRVO

CervoMed (CRVO) Stock Price, News & Analysis

CervoMed logo
$3.92 +0.12 (+3.03%)
As of 01:12 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About CervoMed Stock (NASDAQ:CRVO)

Advanced

Key Stats

Today's Range
$3.81
$4.15
50-Day Range
$3.62
$4.86
52-Week Range
$3.51
$13.13
Volume
34,976 shs
Average Volume
71,544 shs
Market Capitalization
$36.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$23.00
Consensus Rating
Moderate Buy

Company Overview

CervoMed Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
57th Percentile Overall Score

CRVO MarketRank™: 

CervoMed scored higher than 57% of companies evaluated by MarketBeat, and ranked 349th out of 860 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    CervoMed has received a consensus rating of Moderate Buy. The company's average rating score is 2.63, and is based on no strong buy ratings, 6 buy ratings, 1 hold rating, and 1 sell rating.

  • Upside Potential

    CervoMed has a consensus price target of $23.00, representing about 504.2% upside from its current price of $3.81.

  • Amount of Analyst Coverage

    CervoMed has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about CervoMed's stock forecast and price target.
  • Earnings Growth

    Earnings for CervoMed are expected to grow in the coming year, from ($2.31) to ($1.98) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of CervoMed is -1.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of CervoMed is -1.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    CervoMed has a P/B Ratio of 1.93. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about CervoMed's valuation and earnings.
  • Percentage of Shares Shorted

    4.59% of the float of CervoMed has been sold short.
  • Short Interest Ratio / Days to Cover

    CervoMed has a short interest ratio ("days to cover") of 7.72.
  • Change versus previous month

    Short interest in CervoMed has recently decreased by 12.51%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    CervoMed does not currently pay a dividend.

  • Dividend Growth

    CervoMed does not have a long track record of dividend growth.

  • News Coverage This Week

    MarketBeat has tracked 1 news article for CervoMed this week, compared to 4 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, CervoMed insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    35.40% of the stock of CervoMed is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    25.15% of the stock of CervoMed is held by institutions.

  • Read more about CervoMed's insider trading history.
Receive CRVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CervoMed and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CRVO Stock News Headlines

CervoMed (CRVO) Gets a Buy from JonesTrading
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a $1.75 trillion IPO - larger than Saudi Aramco and any tech offering in history. CNBC calls it 'the big market event of 2026.' According to former tech executive and angel investor Jeff Brown, there's a way to claim a stake before the public filing drops, starting with as little as $500.tc pixel
See More Headlines

CRVO Stock Analysis - Frequently Asked Questions

CervoMed's stock was trading at $7.90 at the start of the year. Since then, CRVO stock has decreased by 47.5% and is now trading at $4.1510.

CervoMed Inc. (NASDAQ:CRVO) released its earnings results on Friday, March, 13th. The company reported ($0.88) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.79) by $0.09. The business had revenue of $0.01 million for the quarter, compared to analysts' expectations of $0.84 million. CervoMed had a negative trailing twelve-month return on equity of 96.04% and a negative net margin of 672.80%.

Shares of CRVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that CervoMed investors own include Zomedica (ZOM), Jumia Technologies (JMIA), Nano Dimension (NNDM), NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET) and e.l.f. Beauty (ELF).

Company Calendar

Last Earnings
3/13/2026
Today
5/08/2026
Next Earnings (Estimated)
5/11/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CRVO
Previous Symbol
NASDAQ:CRVO
CIK
1053691
Employees
4
Year Founded
N/A

Price Target and Rating

High Price Target
$31.00
Low Price Target
$11.00
Potential Upside/Downside
+487.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.63
Research Coverage
8 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.98)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$26.97 million
Net Margins
-672.80%
Pretax Margin
-672.97%
Return on Equity
-96.04%
Return on Assets
-82.88%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.91
Quick Ratio
4.91

Sales & Book Value

Annual Sales
$4.01 million
Price / Sales
9.04
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.97 per share
Price / Book
1.99

Miscellaneous

Outstanding Shares
9,260,000
Free Float
5,981,000
Market Cap
$36.25 million
Optionable
Not Optionable
Beta
-0.63
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:CRVO) was last updated on 5/8/2026 by MarketBeat.com Staff.
From Our Partners